UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000016776
Receipt No. R000019460
Scientific Title A phase III, randomized, controlled study of mFOLFOX6 + bevacizumab combination therapy versus mFOLFOX6 + panitumumab combination therapy in chemotherapy-naive patients with KRAS/NRAS wild-type, incurable/unresectable, advanced/recurrent colorectal cancer
Date of disclosure of the study information 2015/03/23
Last modified on 2017/06/14 19:05:53

No. Disposal Last modified on Item of update
1 Insert 2015/03/11 17:07:04
2 Update 2015/03/24 10:16:19 Last name of contact person
Last name of contact person
Name of person sending information
Name of person sending information
3 Update 2015/03/24 10:20:46 Last name of contact person
Last name of contact person
Name of person sending information
Name of person sending information
4 Update 2015/03/24 10:25:35 Email
5 Update 2015/06/16 12:08:17 Key inclusion criteria
Key inclusion criteria
6 Update 2015/06/16 12:09:07 Recruitment status
7 Update 2016/09/12 09:02:01 Key exclusion criteria
8 Update 2016/09/12 09:03:45 Name of primary sponsor
Organization
9 Update 2017/06/14 19:05:53 Recruitment status


Contact us.